Skip to content

Clinical trials

Lipodystrophy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lipodystrophy Country / region: United States Clear all

72 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20012
20023
20032
20044
20057
20067
20072
20081
20091
20102
20111
20123
20132
20145
20152
20162
20185
20192
20221
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59
Recruiting4
Active, not recruiting2
Terminated2
Unknown status2
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)14
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)13
University of Texas Southwestern Medical Center6
Massachusetts General Hospital4
Glaxo Wellcome3
Recros Medica, Inc.2
Theratechnologies2
University of Michigan2
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections1
Aegerion Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lipodystrophy72
HIV Infections36
Insulin Resistance11
Diabetes Mellitus8
Hyperlipidemias7
Hypertriglyceridemia7
Acquired Immunodeficiency Syndrome6
HIV-Associated Lipodystrophy Syndrome4
Lipodystrophy, Congenital Generalized4
Metabolic Syndrome4

Trials

Showing 1 to 25 of 72. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.